Product Information
DEXTROAMPHETAMINE 5 MG TAB is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.3836 per EA under NDC 11534018801. Its NADAC has been published 269 times since Apr 28, 2021.
FDA first approved this application on Oct 18, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534018801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210059FDA Approved
10/18/2017
TE Code
AA
On Market Since
7/4/2018
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE 5 MG TAB has been published 269 times since Apr 28, 2021, and over the history we have for it it has risen 64.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3836 per EA |
|---|---|
| All-time high | $0.6734 (Nov 13, 2024) |
| All-time low | $0.1570 (Feb 23, 2022) |
| 52-week high | $0.5573 |
| 52-week low | $0.3494 |
| Median price | $0.4341 |
| Average price | $0.4280 |
| Largest weekly change | +95.9% (Jul 20, 2022) |
| Weeks tracked | 269 |
| Tracking since | Apr 28, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sunrise Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextroamphetamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE 5 MG TAB, manufactured by Sunrise Pharmaceutical Inc., is $0.3836 per EA (NDC 11534018801), effective Sep 30, 2026.
How has the price of DEXTROAMPHETAMINE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE 5 MG TAB has risen 64.9%. It has been tracked across 269 weekly CMS publications since Apr 28, 2021.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE 5 MG TAB?
Since Apr 28, 2021, the NADAC for DEXTROAMPHETAMINE 5 MG TAB has ranged from a low of $0.1570 (Feb 23, 2022) to a high of $0.6734 (Nov 13, 2024), with a median of $0.4341 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE 5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMPHETAMINE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMPHETAMINE 5 MG TAB?
DEXTROAMPHETAMINE 5 MG TAB (NDC 11534018801) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.